EXODIAMOND Hybrid Trio

Topical plant-derived exosome, 40 billion particles per vial. ISO CGMP, CPNP and SCPN registered. Topical use only.

EXODIAMOND Hybrid Trio (BP-MS20231) is a topical plant-derived exosome formulation at 40 billion particles per vial.

Sources: Panax Ginseng, Resurrection Plant and Houttuynia Cordata, combined in a single lyophilised preparation that is reconstituted on use.

Regulatory position: ISO CGMP manufactured, CPNP and SCPN registered. Topical use only.

Clinics use it to support post-procedure skin recovery protocols after microneedling and laser work.

Supplied in boxes of 5 sessions. Practitioner training and protocol support included. For licensed practitioners and clinics only.

See it at Stand J65 or email info@lavderma.com.

CCR 2026 show offer: order 5 boxes of BP-MS20231 at Stand J65 or by 16 October 2026 and receive a 6th box at no charge. Order 10 boxes and receive 3 boxes at no charge. Both include an in-clinic protocol training session.

Offer terms: UK clinics and licensed practitioners only, one offer per clinic, orders placed by 16 October 2026, subject to availability. Prices exclude VAT and carriage.